Nearly 26% of all women and 13% of all men will develop some form of chronic venous disorder in their lifetime. Until recently, the removal of varicose veins required the actual stripping out of the vein: a surgical procedure that can require a hospital stay because of the painful recovery. The surgical procedure often includes several “stab phlebectomy” incisions which can leave multiple scars and runs the risk of post-operative infections and nerve damage. Today endovenous luminal ablation (EVLA or EndoVascular Laser Therapy) therapy with lasers (Dornier 940 nm) and/or radiofrequency energy (VNUS Covidien) have replaced the need for this type of surgery.
Nearly 30 million American men and women will develop some form of venous disorder in their lifetime. The prevalence of visible varicose veins in women increases with age from 22% at age 40 to 72% by age 60. Men also develop varicose veins but are less likely to seek treatment until symptoms worsen. The genetic prevalence for developing varicose veins has been reported as high as 50 % if your mother has them; 70% if your father has them; and over 90% if both parents have varicose veins.
Varicose veins are typically tortuous blue veins greater than 4 mm in diameter that can cause pain, fatigue, heaviness and swelling in their early stages ( CEAP 2 - CEAP 3). It is vitally important for the public to understand that varicose veins are a health concern worthy of medical diagnosis and treatment. If this condition is allowed to progress it can cause even more serious complications termed Chronic Venous Insufficiency (CVI) which affects the skin near the ankles. Untreated CVI leads to discoloration (hyper pigmentation) and more serious disturbances of skin texture (venous stasis dermatitis, lipodermatosclerosis and atrophie blanche) and can progress in its later stages to venous ulceration at the ankle level (CEAP 4 – CEAP 6).
(CEAP 2 - CEAP 3)
(CEAP 4- CEAP 6)